Skip to main content
. 2022 Jan 21;305(4):1089–1097. doi: 10.1007/s00404-021-06378-z

Table 2.

Stress urinary incontinence operations and urinary incontinence visits after hysterectomy

All hysterectomies (5000) Abdominal hysterectomies (1301) Laparoscopic hysterectomies (1532) Vaginal hysterectomies (2153) p
Any SUI operation (n, %) 111 (2.2) 11 (0.8) 28 (1.8) 71 (3.3)  < 0.05*
 RP-MUS 49 (44.1) 5 (45.5) 16 (57.1) 27 (38.0)
 TO-MUS 59 (53.2) 6 (54.5) 12 (42.9) 41 (57.7)
 Bulking injection 0 0 0 3 (4.2)
 Other 3 (2.7) 0 0 0
Indication for incontinence operation (n, %)
 Stress urinary incontinence 96 (86.5) 10 (90.9) 27 (96.4) 58 (81.7)
 Mixed urinary incontinence 15 (13.5) 1 (9.1) 1 (3.6) 13 (18.3)
Time to operation, median in years (IQR) 3.8 (2.9–7.2) 3.2 (2.0–6.7) 4.6 (2.9–8.2) 3.2 (1.7–6.4) 0.3
Any incontinence visit (n, %) 241 (4.8) 32 (2.5) 68 (4.4) 139 (6.5)  < 0.05*
 Stress urinary incontinence visit 142 (58.9) 18 (56.3) 42 (61.8) 80 (57.6)
 Other urinary incontinence visit 99 (41.1) 14 (43.8) 26 (38.2) 59 (42.4)
 Time to re-visit, median in years (IQR) 3.4 (1.2–6.5) 3.6 (1.5–6.8) 3.9 (1.9–6.9) 2.8 (0.7–6.3) 0.3

SUI stress urinary incontinence, RP-MUS retropubic mid-urethral sling, TO-MUS transobturator mid-urethral sling, POP pelvic organ prolapse, IQR interquartile range

*Statistically significant